Accurate, rapid, and easy-to-use clinical diagnostic tools for AutoImmune Disease and Traumatic Brain Injury
ImmunArray is an early-commercial-stage company developing accurate, rapid, and easy-to-use diagnostic tools for AutoImmune Disease and Traumatic Brain Injury, markets valued at over $1 billion each.
For manufacturing these tools, the company has developed proprietary iCHIP® technology, a scalable platform that enables high throughput.
The company’s initial products are supported by strong clinical research and peer reviews.
ImmunArray is based in Rehovot, Israel and Richmond, Virginia.